Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.51 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.50 |
| ▸ | CALCR | P30988 | 4/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | GLP1R | P43220 | 6/20 | 0.47 |
| ▸ | GIPR | P48546 | 6/20 | 0.47 |
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30567734 | 0.92 | MAPK8 (0.50) | KEAP1CALCRTFPI | |
| SCHEMBL30567693 | 0.87 | GLP1R (0.55) | CALCROPRM1OPRD1GLP1RGIPR | |
| SCHEMBL31042472 | 0.85 | GLP1R (0.55) | CALCROPRM1OPRD1GLP1RGIPR | |
| SCHEMBL31042469 | 0.85 | OPRD1 (0.54) | KEAP1NMUR2NMUR1CALCROPRM1 | |
| SCHEMBL29526507 | 0.84 | KDM1A (0.56) | CALCRGLP1RGIPR | |
| SCHEMBL31656525 | 0.84 | GLP1R (0.56) | CALCROPRM1OPRD1GLP1RGIPR | |
| SCHEMBL31042473 | 0.83 | OPRD1 (0.55) | KEAP1OPRM1OPRD1GLP1RGIPR | |
| SCHEMBL30443604 | 0.83 | NMUR2 (0.55) | KEAP1NMUR2NMUR1CALCRLOPRM1 | |
| SCHEMBL29697094 | 0.83 | CALCR (0.59) | CALCROPRM1OPRD1GLP1RGIPR | |
| SCHEMBL31619585 | 0.82 | GLP1R (0.61) | OPRD1GLP1RGIPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240277841-A2 | HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-08-22 | — | — | US | disclosed |
| US-20240024473-A1 | HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2024-01-25 | — | — | US | disclosed |
| CN-116601290-A | Human chimeric antigen receptor neutrophils, compositions, kits and methods of use | 普渡研究基金会 | 2023-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277841-A2 | HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE | PBK, KIT, MYD88 | KEAP1 3595/4885NMUR2 810/4885NMUR1 730/4885 |
| US-20240024473-A1 | HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE | PBK, KIT, MYD88 | KEAP1 3595/4885NMUR2 810/4885NMUR1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.